Aclaris Therapeutics, Inc. (ACRS)
Total Valuation
ACRS has a market cap or net worth of $88.66 million. The enterprise value is -$30.02 million.
Market Cap | 88.66M |
Enterprise Value | -30.02M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
Earnings Date | May 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ACRS has 70.93 million shares outstanding. The number of shares has increased by 7.05% in one year.
Shares Outstanding | 70.93M |
Shares Change (YoY) | +7.05% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 2.77% |
Owned by Institutions (%) | 95.98% |
Float | 50.39M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.84 |
Forward PS | 15.52 |
PB Ratio | 0.56 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.16 |
Quick Ratio | 3.86 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.80% and return on invested capital (ROIC) is -78.84%.
Return on Equity (ROE) | -52.80% |
Return on Assets (ROA) | -40.20% |
Return on Capital (ROIC) | -78.84% |
Revenue Per Employee | $363,360 |
Profits Per Employee | -$1.03M |
Employee Count | 86 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | -367,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.52% in the last 52 weeks. The beta is 0.23, so ACRS's price volatility has been lower than the market average.
Beta (1Y) | 0.23 |
52-Week Price Change | -84.52% |
50-Day Moving Average | 1.21 |
200-Day Moving Average | 4.71 |
Relative Strength Index (RSI) | 54.24 |
Average Volume (30 Days) | 1,786,544 |
Short Selling Information
The latest short interest is 5.12 million, so 7.22% of the outstanding shares have been sold short.
Short Interest | 5.12M |
Short Previous Month | 6.10M |
Short % of Shares Out | 7.22% |
Short % of Float | 10.16% |
Short Ratio (days to cover) | 4.32 |
Income Statement
In the last 12 months, ACRS had revenue of $31.25 million and -$88.48 million in losses. Loss per share was -$1.27.
Revenue | 31.25M |
Gross Profit | 13.17M |
Operating Income | -124.26M |
Pretax Income | -88.85M |
Net Income | -88.48M |
EBITDA | -87.99M |
EBIT | -88.85M |
Loss Per Share | -$1.27 |
Balance Sheet
The company has $119.11 million in cash and $426,000 in debt, giving a net cash position of $118.68 million or $1.67 per share.
Cash & Cash Equivalents | 119.11M |
Total Debt | 426,000 |
Net Cash | 118.68M |
Net Cash Per Share | $1.67 |
Equity / Book Value | 157.18M |
Book Value Per Share | 2.22 |
Working Capital | 97.90M |
Cash Flow
In the last 12 months, operating cash flow was -$78.33 million and capital expenditures -$1.31 million, giving a free cash flow of -$79.63 million.
Operating Cash Flow | -78.33M |
Capital Expenditures | -1.31M |
Free Cash Flow | -79.63M |
FCF Per Share | -$1.14 |
Margins
Gross margin is 42.14%, with operating and profit margins of -397.64% and -283.15%.
Gross Margin | 42.14% |
Operating Margin | -397.64% |
Pretax Margin | -284.32% |
Profit Margin | -283.15% |
EBITDA Margin | -281.56% |
EBIT Margin | -284.32% |
FCF Margin | -254.84% |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.05% |
Shareholder Yield | -7.05% |
Earnings Yield | -99.80% |
FCF Yield | -89.82% |
Analyst Forecast
The average price target for ACRS is $11.50, which is 816.34% higher than the current price. The consensus rating is "Hold".
Price Target | $11.50 |
Price Target Difference | 816.34% |
Analyst Consensus | Hold |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 12.29% |
EPS Growth Forecast (5Y) | 3.00% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -4.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.88 |
Piotroski F-Score | 2 |